Search Results - "BelHadjAli, Zaher"

Recurrent differentiation syndrome or septic shock? Unresolved dilemma in a patient with acute promyelocytic leukemia by Jeddi, Ramzi, Ghédira, Hela, Amor, Ramzi Ben, Menif, Samia, Belhadjali, Zaher, Meddeb, Balkis

“…Differentiation syndrome (DS) is a life-threatening complication observed in patients with acute promyelocytic leukemia (APL) receiving induction therapy with…”
Get full text

TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA WITH AIDA BASED REGIMEN by Jeddi, Ramzi, Ghédira, Hèla, Ben Amor, Ramzi, Ben Abdennebi, Yosr, Karima, Kacem, Mohamed, Zarrouk, Ben Neji, Hend, Aissaoui, Lamia, Ben Lakhal, Raihane, Ben Salah, Naouel, Menif, Samia, Belhadjali, Zaher, Ben Abid, Hela, Gouider, Emna, Hafsia, Raouf, Saad, Ali, Fenaux, Pierre, Meddeb, Balkis

“…In Tunisia, the ATRA era began in 1998 with the use, consecutively, of two regimens combining ATRA and an anthracycline with cytarabine (APL93), and without…”
Get full text

Factors associated with severe sepsis: prospective study of 94 neutropenic febrile episodes by Jeddi, Ramzi, Achour, Mériem, Amor, Ramzi Ben, Aissaoui, Lamia, Bouterâa, Walid, Kacem, Karima, Lakhal, Raihane Ben, Abid, Héla Ben, BelHadjAli, Zaher, Turki, Amel, Meddeb, Balkis

“…Severe sepsis defined as infection-induced organ dysfunction or hypoperfusion abnormalities predispose to septic shock and increased mortality in neutropenic…”
Get more information

ATRA and anthracycline-based chemotherapy in the treatment of childhood acute promyelocytic leukemia (APL): A 10-year experience in Tunisia by Jeddi, Ramzi, Ghédira, Hèlà, Ben Abdennebi, Yosr, Kacem, Karima, Ben Amor, Ramzi, Aissaoui, Lamia, Bouterâa, Walid, Ben Lakhal, Raihane, Ben Abid, Hèla, Menif, Samia, Belhadjali, Zaher, Meddeb, Balkis

“…Reports on childhood APL from developing countries are scarce. We treated 65 APL with two consecutive trials combining ATRA and chemotherapy. Twenty (30.7%)…”
Get full text

Predictive Factors of Severe Sepsis and Septic Shock in Patients with Hematological Malignancies and Pseudomonas Infections by Jeddi, Ramzi, Ghédira, Hèla, Amor, Ramzi ben, Aissaoui, Lamia, Kacem, Karima, Bouterâa, Walid, Abdennebi, Yosr ben, Lakhal, Raihane ben, Turki, Amel, Abid, Hèla ben, Belhadjali, Zaher, Meddeb, Balkis

“…Abstract 4552 Pseudomonas aeruginosa is a leading cause of nosocomial infections usually associated with high mortality. The aim of this study was to determine…”
Get full text

Predictive factors of septic shock and mortality in neutropenic patients by Ramzi, Jeddi, Mohamed, Zarrouk, Yosr, Benabdennebi, Karima, Kacem, Raihane, Benlakhal, Lamia, Aissaoui, Hela, Ben Abid, Zaher, Belhadjali, Balkis, Meddeb

“…Neutropenia is a major risk factor for developing a serious infection. Bacteremia still causes significant mortality among neutropenic patients with cancer…”
Get more information

Predictive Factors of All Trans-Retinoic Acid (ATRA) Related Complications during Induction Course of Acute Promyelocytic Leukemia (APL) by Ramzi, Jeddi, Karima, Kacem, Hend, Benneji, Samia, Mnif, Raihane, Belakhal, Lamia, Aissaoui, Hela, Benabid, Zaher, Belhadjali, Balkis, Meddeb

“…Background: The combination of ATRA and chemotherapy has made APL a highly curable leukemia. However several complications are reported with this treatement…”
Get full text

Predictive factors of all-trans-retinoic acid related complications during induction therapy for acute promyelocytic leukemia by Jeddi, Ramzi, Kacem, Karima, Ben Neji, Hend, Mnif, Samia, Gouider, Emna, Aissaoui, Lamia, Ben Amor, Ramzi, Ben Lakhal, Raihane, Ben Abid, Hela, Belhadjali, Zaher, Meddeb, Balkis

“…The combination of all-trans-retinoic acid (ATRA) and chemotherapy has made acute promyelocytic leukemia (APL) a highly curable leukemia. However, several…”
Get full text

Treatment of acute promyelocytic leukemia with PETHEMA LPA 99 protocol: a Tunisian single center experience by Jeddi, Ramzi, Ghédira, Héla, Menif, Samia, Ben Neji, Hend, Ben Amor, Ramzi, Kacem, Karima, Aissaoui, Lamia, Bouteraâ, Walid, Abdennebi, Yosr, Raihane, Ben Lakhal, Gouider, Emna, Raouf, Hafsia, Hèla, Ben Abid, Saad, Ali, Zaher, Belhadjali, Meddeb, Balkis

“…Acute promyelocytic leukemia (APL) has now become the most curable of all subtypes of acute myeloid leukemia. A cure rate of 75-80% can be anticipated with a…”
Get full text

Treatment of Acute Promyelocytic Leukemia with AIDA Based Regimen. Update of a Tunisian Single Center Study by Jeddi, Ramzi, Ghédira, Hèla, Ben Amor, Ramzi, Ben Abdennebi, Yosr, Karima, Kacem, Mohamed, Zarrouk, Ben Neji, Hend, Aissaoui, Lamia, Ben Lakhal, Raihane, Ben Salah, Naouel, Menif, Samia, Belhadjali, Zaher, Ben Abid, Hela, Gouider, Emna, Hafsia, Raouf, Saad, Ali, Fenaux, Pierre, Meddeb, Balkis

“…In Tunisia, the ATRA era began in 1998 with the use, consecutively, of two regimens combining ATRA and an anthracycline with cytarabine (APL93), and without…”
Get full text

TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA WITH AIDA BASED REGIMEN by Hela Ben Abid, Zaher Belhadjali, Samia Menif, Naouel Ben Salah, Raihane Ben Lakhal, Lamia Aissaoui, Hend Ben Neji, Zarrouk Mohamed, Kacem Karima, Yosr Ben Abdennebi, Ramzi Ben Amor, Hèla Ghédira, Ramzi Jeddi, Emna Gouider, Raouf Hafsia, Ali Saad, Pierre Fenaux, Balkis Meddeb

“…In Tunisia, the ATRA era began in 1998 with the use, consecutively, of two regimens combining ATRA and an anthracycline with cytarabine (APL93), and without…”
Get full text

Hemoglobin C disease: report of 16 Tunisian cases by Hafsia, Raouf, Marrakchi, Olfa, Ben Salah, Naouel, Gouider, Emna, Ben Lakhal, Ryhane, Jeddi, Ramzi, Aissaoui, Lamia, Belhadjali, Zaher, Ben Abid, Hela, Meddeb, Balkis, Hafsia, Aïcha

“…was to provide the clinical and biological patterns hemoglobine disease in Tunisia. This retrospective study collected to 16 cases of hemoglobin C disease : 6…”
Get more information